Bullboard - Stock Discussion Forum Petros Pharmaceuticals Inc PTPI

Healthcare

Petros Pharmaceuticals, Inc. is a pharmaceutical company focused on expanding consumer access to medication through over-the-counter (OTC) drug development programs. The Company is pursuing access to its flagship prescription erectile dysfunction (ED) therapy, Stendra, via potential OTC designation. Stendra is a Phosphodiesterase - 5 (PDE - 5) inhibitor prescription medication for the treatment... see more

Add To Watchlist

NDAQ:PTPI - Post Discussion

Petros Pharmaceuticals Inc > Petros Pharmaceuticals Reports Positive Results in an Initia

View:

Post by whytestocks on Apr 02, 2024 7:15pm

Petros Pharmaceuticals Reports Positive Results in an Initia

JUST IN: $PTPI Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (avanafil) as it Pursues OTC StatusNitrate patients subgroup demonstrated 100% correct self-selection when utilizing the web app technology with the drug facts label compared to 40% when using drug facts label alone (among 86% vs. 56% of all users) underscoring the significant potential benefits of technology assistance in an OTC ...PTPI - Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (avanafil) as it Pursues OTC Status